Angelini Ventures is the venture capital arm of Angelini Industries funded with a €300 million capital commitment. Angelini Ventures builds and invests in early-stage companies that develop innovative ideas and solutions in biotechnology, digital health and life sciences. Angelini Ventures will invest across Europe, North America, and Israel with a focus on brain health and consumer segments such as women, children and the elderly. The company is headquartered in Rome with a global team spread across Europe, Asia and the US to provide global perspective and capabilities.